Inflammation as a Modifiable Driver of Ischemic Heart Disease: Mechanisms, Clinical Risks, and Evolving Therapeutic Options. Journal of Carcinogenesis, [S. l.], v. 24, n. 10s, p. 488–501, 2025. DOI: 10.64149/J.Carcinog.24.10s.488-501. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/1693. Acesso em: 17 mar. 2026.